ITGR vs. MASI, LIVN, TMDX, CNMD, SLNO, INMD, CRNX, PACS, SMMT, and INSM
Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Masimo (MASI), LivaNova (LIVN), TransMedics Group (TMDX), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), Crinetics Pharmaceuticals (CRNX), PACS Group (PACS), Summit Therapeutics (SMMT), and Insmed (INSM). These companies are all part of the "medical" sector.
Integer (NYSE:ITGR) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, community ranking, valuation, earnings, risk, dividends, profitability and analyst recommendations.
Integer presently has a consensus price target of $128.67, indicating a potential upside of 6.41%. Masimo has a consensus price target of $138.71, indicating a potential upside of 11.78%. Given Masimo's higher possible upside, analysts plainly believe Masimo is more favorable than Integer.
In the previous week, Integer had 3 more articles in the media than Masimo. MarketBeat recorded 18 mentions for Integer and 15 mentions for Masimo. Integer's average media sentiment score of 0.63 beat Masimo's score of 0.56 indicating that Integer is being referred to more favorably in the media.
Integer has higher earnings, but lower revenue than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.
Integer has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.
Integer has a net margin of 6.01% compared to Masimo's net margin of 4.01%. Masimo's return on equity of 13.26% beat Integer's return on equity.
99.3% of Integer shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 2.0% of Integer shares are owned by company insiders. Comparatively, 9.7% of Masimo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Masimo received 76 more outperform votes than Integer when rated by MarketBeat users. Likewise, 63.84% of users gave Masimo an outperform vote while only 63.51% of users gave Integer an outperform vote.
Summary
Integer and Masimo tied by winning 9 of the 18 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
